Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03498716
Brief Title: A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer (IMpassion030)

First Submitted : February 28, 2018
First Submitted that Met QC Criteria : April 12, 2018
First Posted : April 17, 2018

Last Update Submitted that Met QC Criteria : August 12, 2019
Last Update Posted : August 14, 2019